Robert Haupt
Affiliations: | University of Maryland School of Medicine, Baltimore, MD, United States |
Google:
"Robert Haupt"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Logue J, Johnson RM, Patel N, et al. (2023) Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants. Nature Communications. 14: 1130 |
| Haupt R, Baracco L, Harberts EM, et al. (2023) Enhancing the protection of influenza virus vaccines with BECC TLR4 adjuvant in aged mice. Scientific Reports. 13: 715 |
| Jha A, Barker D, Lew J, et al. (2022) Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection. Scientific Reports. 12: 16956 |
| Logue J, Chakraborty AR, Johnson R, et al. (2022) PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19. Communications Biology. 5: 808 |
| Nanishi E, Borriello F, O'Meara TR, et al. (2022) An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice. Science Translational Medicine. 14: eabj5305 |
| Boras B, Jones RM, Anson BJ, et al. (2021) Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19. Nature Communications. 12: 6055 |
| Haupt RE, Harberts EM, Kitz RJ, et al. (2021) Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection. Vaccine |
| Nanishi E, Borriello F, O'Meara TR, et al. (2021) Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity. Biorxiv : the Preprint Server For Biology |
| Si L, Bai H, Rodas M, et al. (2021) A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. Nature Biomedical Engineering |
| Tian JH, Patel N, Haupt R, et al. (2021) SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice. Nature Communications. 12: 372 |